CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
CITY THERAPEUTICS, INC.
$21.46−0.94 (-4.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for City Therapeutics.